Renal cell carcinoma id 10

Renal cell carcinoma (RCC), rudzi rwakawanda rwekenza yetsvo, inorongedzerwa uchishandisa International Classification of Diseases, Tenth Revision (ICD-10) yekuongorora uye nhamba yezvinangwa. Kunzwisisa zvakananga ICD-10 macode akabatana nawo renal cell carcinoma kwakakosha pakuchengeta marekodhi, kubhadhara, nekutsvakurudza. Ichi chinyorwa chinopa rondedzero yakadzama yezvakakodzera ICD-10 macode, staging, diagnostic, uye nzira dzekurapa dze renal cell carcinoma.Kunzwisisa ICD-10 Codes for Renal Cell CarcinomaThe International Classification of Diseases, Gumi Revision (ICD-10) inzira inozivikanwa pasi rose yekuisa zvirwere uye mamiriro ehutano. For renal cell carcinoma, macode chaiwo anoshandiswa kuona rudzi, nzvimbo, uye danho regomarara. Kunyatsokodha kwakakosha pakuunganidza data chaiko, kushuma, uye kudzosera. Iwo macode ari pasi apa anogona kushandiswa navanachiremba kumasangano akaita se Shandong Baofa Cancer Research Institute.Primary Malignancy CodesThe primary ICD-10 kodhi yeakaipa neoplasms yeitsvo ndeyeC64. Iyi kodhi inosanganisira akati wandei madiki anoenderera mberi nekutsanangura nzvimbo uye lateral (yeruboshwe kana kurudyi itsvo): C64.1 - Yakashata neoplasm yeitsvo yekurudyi, kunze kwerenal pelvis C64.2 - Yakashata neoplasm yeruboshwe itsvo, kunze kwerenal pelvis C64.9 - Inokuvadza neoplasm yeitsvo isina kutaurwa, kunze kwerenal pelvisSecondary Malignancy Codes renal cell carcinoma ine metastasized (yakapararira) kune dzimwe nhengo dzemuviri, yechipiri malignancy codes inoshandiswa kuwedzera kune yekutanga code. Mienzaniso inosanganisira: C79.0 -Sekondari yakaipa neoplasm yeitsvo uye renal pelvis (Iyi yaisazoshandiswa seyo yekutanga kodhi ye renal cell carcinoma.) C79.51 -Secondary malignant neoplasm yemapfupa C78.0 -Secondary malignant neoplasm yemapapu C77.3 -Secondary malignant neoplasm yeaxilla uye yekumusoro limb lymph nodeKuongororwa uye Staging yeRenal Cell Carcinoma Kuongororwa kwakakodzera uye danho kwakakosha pakuona chirongwa chakakodzera chekurapa renal cell carcinoma. Nzira dzinotevera dzinowanzo shandiswa: Diagnostic Procedures Imaging Tests: CT scans, MRIs, uye ultrasounds anoshandiswa kuona itsvo uye kuona mamota angangoita. Biopsy: Sample yetishu inotorwa kubva muhuremu hweitsvo uye inoongororwa pasi pemaikorosikopu kuratidza kuvepo kwemasero egomarara. Weti Miyedzo: Inogona kuona ropa kana zvimwe zvisizvo zvinoratidza matambudziko eitsvo. Kuongororwa ropa: Ongorora kushanda kweitsvo uye hutano hwese.TNM Staging SystemThe TNM staging system inoshandiswa zvakanyanya kurongedza huwandu hwe renal cell carcinoma: T (Tumor): Inotsanangura kukura uye kukura kwebundu rekutanga. N (Nodes): Inoratidza kana gomarara rapararira kumalymph nodes ari pedyo. M (Metastasis): Inotarisa kana gomarara rave nemetastasized kunzvimbo dziri kure.Matanho eTNM anotangira kubva paStage I (localized bundu) kusvika kuStage IV (metastatic disease). Danho ndiro chinhu chakakosha pakuona fungidziro uye nzira dzekurapa.Kurapwa Options for Renal Cell CarcinomaKurapa kwe renal cell carcinoma zvinoenderana nezvinhu zvakati kuti, zvinosanganisira danho regomarara, utano hwemurwere hwese, uye zvaanoda. Nzira dzekurapa dzakajairwa dzinosanganisira:Kuvhiya Kubviswa kwebundu kazhinji ndiko kurapwa kwekutanga kwenzvimbo renal cell carcinoma. Sarudzo dzekuvhiya dzinosanganisira: Chikamu Nephrectomy: Kubviswa kwebundu uye muganhu muduku wehutano hwakanaka. Radical Nephrectomy: Kubviswa kweitsvo yese, tishu dzakatenderedza, uye malymph nodes.Targeted TherapyTargeted therapy drugs inovhara mamorekuru chaiwo ane chekuita negomarara sero kukura uye kurarama. Iyi mishonga inogona kushanda kune yepamusoro renal cell carcinoma uye inowanzoshandiswa apo kuvhiyiwa hakusi sarudzo kana mushure mekuvhiyiwa kudzivirira kudzoka zvakare. Mienzaniso inosanganisira: Sunitinib (Sutent) Pazopanib (Votrient) Axitinib (Inlyta) Cabozantinib (Cabometyx)ImmunotherapyImmunotherapy mishonga inosimudzira immune system yemuviri kurwisa maseru egomarara. Mishonga iyi yakaratidza mhedzisiro inovimbisa mukurapa kwepamusoro renal cell carcinoma. Mienzaniso inosanganisira: Nivolumab (Opdivo) Pembrolizumab (Keytruda) Ipilimumab (Yervoy)Radiation TherapyRadiation therapy inoshandisa mwaranzi ine simba guru kuuraya masero egomarara. Dzimwe nguva inoshandiswa kurapa renal cell carcinoma iyo yakapararira kune dzimwe nhengo dzomuviri kana kuti kuderedza zviratidzo zvakadai sekurwadziwa.Active SurveillanceKumamota maduku, anononoka kukura, kunyatsoongorora (kunyatsocherechedza) kunogona kuva sarudzo. Izvi zvinosanganisira ongororo dzenguva dzose dzekutarisa kukura kwebundu, nekurapwa kunotanga kana bundu rikatanga kukura kana kukonzera zviratidzo.Prognosis and Survival Rates renal cell carcinoma zvinosiyana zvichienderana nedanho regomarara uye zvimwe zvinhu. Early-nhanho renal cell carcinoma ane mwero wepamusoro wekupona mushure mekuvhiyiwa kubviswa. Zvisinei, mberi renal cell carcinoma yakanyanya kuoma kurapa, uye mwero wekupona wakaderera. Kufambira mberi mukurapa kwakanangwa uye immunotherapy kwakavandudza kufungidzira kwevarwere vane chirwere chepamusoro.Tafura inotevera inoratidza inosvika makore mashanu ekupona kwematanho akasiyana-siyana. renal cell carcinoma zvichibva pamashoko kubva kuAmerican Cancer Society: Danho 5-Year Survival Rate Danho I 93% Danho II 81% Danho III 74% Danho IV 13% *Nyero yekupona ifungidziro uye inogona kusiyana zvichienderana nemamiriro emunhu. MhedzisoKunzwisisa ICD-10 coding system ye renal cell carcinoma, pamwe chete nekuongororwa kwayo, matanho, uye nzira dzekurapa, zvakakosha kune vashandi vehutano nevarwere. Kukurumidza kuona uye kurapwa kwakakodzera kunogona kuvandudza zvakanyanya mhedzisiro. Kuti uwane rumwe ruzivo nezve cancer yekutsvaga uye kurapwa, ndapota shanya iyo Shandong Baofa Cancer Research Institute nezvedu peji.Disclaimer: Mashoko aya ndeezvinangwa zvekudzidzisa chete uye haafanire kutorwa sezano rekurapa. Bvunza nanyanzvi wezvehutano ane hunyanzvi pane chero zvinetswa nezvehutano kana usati waita chero sarudzo dzine chekuita nehutano hwako kana kurapwa.Kwakabva American Cancer Society: https://www.cancer.org/ National Cancer Institute: https://www.cancer.gov/